Purchases and Sales Made in Q4 2024 in Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN) during Q4 2024. The information is specifically focused on institutions that hold shares of Viridian Therapeutics, Inc.\DE.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-208K- 61.45% |
$3.72M - $5.36M
|
131K
$2.14M
|
|
|
Feb 18, 2025
Q4 2024
|
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
Warszawa, R9 |
SELL
|
- |
-210K- 33.14% |
$3.75M - $5.39M
|
423K
$6.94M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-271K- 26.81% |
$4.83M - $6.96M
|
739K
$12.1M
|
|
|
Feb 13, 2025
Q4 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-271K- 82.9% |
$4.84M - $6.97M
|
55.9K
$917K
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-302K- 45.22% |
$5.39M - $7.77M
|
366K
$6M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-303K- 86.32% |
$5.41M - $7.79M
|
48K
$788K
|
|
|
Feb 13, 2025
Q4 2024
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-365K- 69.6% |
$6.52M - $9.39M
|
160K
$2.62M
|
|
|
Feb 13, 2025
Q4 2024
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-696K- 41.45% |
$12.4M - $17.9M
|
983K
$16.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-1.08M- 37.15% |
$19.2M - $27.7M
|
1.82M
$29.8M
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-1.33M- 47.15% |
$23.7M - $34.1M
|
1.49M
$24.4M
|